BTN3A1, CD277, BTF5
Human BTN3A1 / CD277 Protein, Fc Tag, Gln 30 - Gly 254 (Accession # AAI21801) was produced in human 293 cells (HEK293) at ACROBiosystems.
Human BTN3A1, Fc Tag is fused with a human IgG1 Fc tag at the C-terminus, and has a calculated MW of 50.8 kDa. The predicted N-terminus is Gln 30. As a result of glycosylation, the reducing (R) protein migrates as 55 kDa, and the non-reducing (NR) protein migrates as 100-120 kDa in SDS-PAGE.
Less than 1.0 EU per μg by the LAL method.
>95% as determined by SDS-PAGE.
Lyophilized from 0.22 μm filtered solution in 50 mM tris, 100 mM glycine, pH7.5. Normally Trehalose is added as protectant before lyophilization.
Contact us for customized product form or formulation.
See Certificate of Analysis for reconstitution instructions and specific concentrations.
Avoid repeated freeze-thaw cycles.
No activity loss was observed after storage at:
In lyophilized state for 1 year (4°C); After reconstitution under sterile conditions for 3 months (-70°C).
Butyrophilin subfamily 3 member A1 (BTN3A1) is also known as CD277 and BTF5, which belongs to the immunoglobulin superfamily and contains one B30.2/SPRY domain and two Ig-like V-type (immunoglobulin-like) domains. BTN3A1 plays a role in T-cell activation and in the adaptive immune response. Also, BTN3A1 regulates the proliferation of activated T-cells and the release of cytokines and IFNG by activated T-cells. Furthermore, BTN3A1 mediates the response of T-cells toward infected and transformed cells that are characterized by high levels of phosphorylated metabolites, such as isopentenyl pyrophosphate.
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.